ABSTRACT: Critical bone defects pose a formidable orthopaedic problem in patients with bone loss. We developed a preclinical model based on the induced membrane technique using a synthetic graft to replace autograft for healing critical bone defects. Additionally, we used a novel osteoconductive scaffold coupled with a synthetic membrane to evaluate the potential for single-stage bone regeneration. Three experimental conditions were investigated in critical femoral defects in rats. Group A underwent a two-stage procedure with insertion of a polymethylmethacrylate (PMMA) spacer followed by replacement with a 3D printed polycaprolactone(PCL)/b-tricalcium phosphate (b-TCP) osteoconductive scaffold after 4 weeks. Group B received a single-stage PCL/b-TCP scaffold wrapped in a PCLbased microporous polymer film creating a synthetic membrane. Group C received a single-stage bare PCL/b-TCP scaffold. All groups were examined by serial radiographs for callus formation. After 12 weeks, the femurs were explanted and analyzed with micro-CT and histology. Mean callus scores tended to be higher in Group A. Group A showed statistically significant greater bone formation on micro-CT compared with other groups, although bone volume fraction was similar between groups. Histology results suggested extensive bone ingrowth and new bone formation within the macroporous scaffolds in all groups and cell infiltration into the microporous synthetic membrane. This study supports the use of a critical size femoral defect in rats as a suitable model for investigating modifications to the induced membrane technique without autograft harvest. Future investigations should focus on bioactive synthetic membranes coupled with growth factors for single-stage bone healing. ß
Clinical management of critical sized bone defects remains a significant challenge to the orthopaedic surgeon. These segmental defects are secondary to trauma, infection, tumor resection, or developmental deformities.
1,2 By definition, critical sized bone defects are those that will not heal spontaneously, despite surgical stabilization, without some form of augmentation. 3 It is estimated that over one million fractures require bone transplantation each year in the Unites States with an economic burden of $3 billion USD per year. 4 Although amputation is a reasonable alterative to reconstructive procedures, it is associated with three times higher lifetime health-care cost in patients with severely injured lower extremities. 5 Consequently, a variety of techniques have been developed to promote union in patients with critical bone defects. 2 The induced membrane, or traditional Masquelet, technique is a two-step surgical procedure used for the repair of critical size bone defects. 6, 7 During the initial phase of reconstruction, a polymer spacer induces the production of a vascularized fibrous membrane surrounding the defect site. A secondary surgery is then performed to remove the spacer and replace it with a bone graft inside the newly induced membrane. This two-stage technique yields higher rates of bone healing compared to implanting an equivalent bone graft at the critical defect site initially, since the induced membrane provides a privileged environment for bone regeneration, hypothetically, by producing osteoinductive growth factors, supplying a robust source of blood vessels, and sequestering the defect site to prevent bone graft resorption and the invasion of fibrous tissue. [8] [9] [10] [11] However, the entire procedure requires at least two surgeries with around one in four patients requiring further union surgery or another type of re-intervention. 12 Furthermore, the traditional induced membrane technique necessitates autologous bone graft harvest, which is associated with significant donor site morbidity and additional risks for the patient. 13 Alternatives to the induced membrane technique for healing critical bone defects include allograft bone grafting, distraction osteogenesis and bone transport, and vascularized fibular autograft implantation.
2 Each strategy has its own unique set of disadvantages. Cancellous allograft, although readily available to the surgeon, lacks the structural support of cortical bone for critical defects, is associated with increased risk of disease transmission, and is not osteoinductive or osteogenic. 14, 15 Cadaveric allograft is most often used for large oncologic reconstructive procedures rather than in traumatically injured patients given its high complication rate to include nonunion, fracture, and infection. [16] [17] [18] Distraction osteogenesis is a process by which cortical contact is made between the free bone ends of the defect and the fracture site is gradually distracted at a rate of 1 mm/day. Although effective, this technique subjects the patient to a prolonged treatment course to recover the loss of long bone length and typically employs a large, cumbersome external ring fixator. 16 Vascularized fibular grafts are autologous cortical struts that can be implanted into the defect and anastomosed to the local blood supply with microsurgery. However, these grafts can be technically very challenging and often create a mismatch in morphology between the long bone defect and the bridging free fibula. These grafts are associated with significant donor site morbidity as well.
Synthetic bone void fillers, which present an alternative to autograft and allograft, have the advantages of greater reproducibility and ease of customization without the need for graft harvesting or the risks of disease transmission. The most common synthetic bone void fillers are b-tricalcium phosphate (b-TCP), hydroxyapatite, or combinations of the two. 19 These ceramics show excellent biocompatibility and osteoconductivity, enabling their use as scaffolds for bone regeneration. However, the brittleness of these materials renders them unsuitable for load bearing applications. 20, 21 Composite materials combining a calcium phosphate ceramic with a structurally supportive polymer such as polycaprolactone (PCL) provide greater structural integrity within the defect site. PCL is a bioresorbable polymer well suited for bioengineered scaffolds due to its excellent biocompatibility and its ability to be easily combined with other materials and processed by 3D printing methods. 22 Scaffolds made from composites of PCL/b-TCP have been studied for application in tissue engineering and regenerative medicine, and have been shown to support cell proliferation in vitro and improve bone tissue regeneration across defects in vivo. 23, 24 Both PCL and b-TCP have been approved for clinical application in patients by the FDA and demonstrate low toxicity and inflammatory responses. 19, 25, 26 However, implants constructed from these materials lack the growth factors and living cells that enable autologous grafts to actively contribute to the native bone healing response. Furthermore, synthetic bone void filler alone still faces challenges in healing large bone defects because of limited re-vascularization. For this reason, we proposed to apply a PCL/b-TCP scaffold in conjunction with a Masquelet-inspired procedure, as we hypothesized the induced membrane could furnish the synthetic implant with osteoinductive growth factors and a rich vascular environment to promote bone healing. [8] [9] [10] [11] 27 Ultimately, we aim to develop an acellular technique whereby a synthetic scaffold can be inserted into a critical long bone defect to facilitate union without autologous bone graft. Moreover, the ideal tissue engineered solution for critical bone loss would be employed as a single-step procedure. With this goal, we designed a 3D printed biodegradable composite PCL/b-TCP osteoconductive scaffold to substitute as bone graft and a synthetic PCL-based microporous polymer film to create an artificial induced membrane inspired by the traditional Masquelet technique. 28, 29 The purpose of this study was: (i) to establish a novel two-stage induced membrane rodent model utilizing a synthetic implant to replace autologous bone graft; and (ii) to introduce a singlestage modification intended to evaluate engineered membranes in this small animal model for single step bone healing.
METHODS

Scaffold Preparation
Porous cylindrical scaffolds (5 mm diameter, 8 mm length) made from a composite of 80% PCL and 20% b-TCP were printed using the fused deposition modeling (FDM) module (nozzle diameter 300 mm) of our custom designed in-house 3D printer, Hybprinter. 28 To prepare the PCL/b-TCP composite, PCL (Mn ¼ 80,000 g/mol, Sigma-Aldrich) was dissolved in dimethyl formamide (DMF) at 70˚C. Nano-b-TCP powder (particle size 100 nm; Berkeley Advanced Biomaterials Inc., Berkeley, CA) was then added to the solution and stirred vigorously to form a suspension. Once even distribution of the ceramic powder was achieved, the suspension was quickly poured into a water bath to induce immediate precipitation of the PCL/b-TCP composite. Residual DMF was removed by repeated submersion in fresh water. The PCL/b-TCP was air dried and processed into filaments for FDM 3D printing using a screw-based filament extruder. The scaffolds were printed as orthogonally oriented consecutive layers of parallel struts, with a layer thickness of 300 mm and a distance between struts of 500 mm (Fig. 1) . Once printed, all scaffolds were treated with 5M NaOH for 12 h at room temperature to increase surface roughness and wettability for improved tissue ingrowth. The curved outer surface of some of the scaffolds was then wrapped in a polymer sheath made from PCL (Mn 80,000 g/mol) modified as previously reported by end group functionalization with hexamethylene diisocyanate and p-hydroxycinnamic acid. 30 The membranes were fabricated using a phase inversion method wherein an acrylic plate coated in a DMF solution of the polymer was submerged in water, inducing precipitation of the polymer to yield flexible and tough microporous membranes (Fig. 1) . The membrane pore size was analyzed by ImageJ software and was found to range between 0.2 and 5.5 mm, with a mean pore size of 1.6 AE 0.8 mm. The polymer sheath was then cut to size and sealed by application of minimal DMF, which was subsequently removed by submersion in water. The scaffolds were sterilized in 70% ethanol for 30 min and dried under sterile conditions.
Surgical Technique
All animal experiments were approved and performed following our institution Animal Care and Use Committee (APLAC-30586) guidelines. 24 Sprague-Dawley rats (male; 11 weeks old; Charles River Laboratories) were used in total, with 8 animals per experimental group. The right femur of each rat was stabilized with a custom 22 mm polyetherether ketone (PEEK) plate with four threaded 0.7 mm K-wires and an 8 mm defect was then created in the femoral shaft centered between the K-wires using a 0.22 mm Gigli wire saw (RISystem, Davos, Switzerland). Group A received an initial PMMA spacer (fabricated in lab for friction fit at free bone ends; Sigma-Aldrich) for 4 weeks (Fig. 2) , after which the site was reopened and the spacer was replaced by a bare PCL/b-TCP scaffold for 12 weeks. Group B received a PCL/b-TCP scaffold with synthetic sheath for 12 weeks. Group C received a bare PCL/b-TCP scaffold for 12 weeks. At the final time points, the animals were euthanized and the operated femurs removed. The contralateral femurs were also harvested as controls.
Post-Operative Evaluation
All groups were examined by radiograph at 1, 4, 8, and 12 weeks after insertion of the PCL/b-TCP scaffold for callus formation and bridging (Fig. 3) , as determined by two blinded observers (M.R.D, orthopaedic senior resident, and M.J.G, chief attending of orthopaedic trauma). Callus formation was scored on a three point system where a score of 0 ¼ no healing, 1 ¼ partial healing, 2 ¼ full union. 31 After the final time point, the explanted femurs were scanned in saline by micro-CT (100 kV, 50 mA, 20 ms, isotropic voxel size 49 mm, four averaged frames per projection; eXplore CT120, TriFoil Imaging Inc., Los Angeles, CA). Microview software (Parallax Innovations, Ilderton, ON, Canada) was used to fit contours to the outer boundary of the callus in each slice in order to generate a complex region of interest (ROI) matching the callus volume (Fig. 4) . The proximal and distal ends of the ROI were defined using the K-wires anchoring the femur to the fixation plate as landmarks. Thresholds to differentiate between mineralized and unmineralized tissues and the PCL/b-TCP scaffolds were determined, as previously reported. 28, 32 Mineralized bone tissue was defined by a lower threshold of 550 and an upper threshold of 2000 for all samples. The total volume of the callus (TV), the volume of mineralized tissue within the callus (BV), and the bone mineral density (BMD) were then calculated by the Microview software and callus union was scored using a system adapted from Mehta et al. where Scoring was carried out by blinded observers. The regenerated tissues within the PCL/b-TCP scaffolds were additionally examined by histological analysis. Randomly selected explanted femurs from each surgical group (n ¼ 3) were fixed in 4% paraformaldehyde for 24 h, cleaned of surrounding muscle tissues, and decalcified in a solution of 20% ethylenediaminetetraacetic acid (EDTA) in PBS (pH 7.4) at 25˚C. The samples were then dehydrated in graded ethanol (70, 85, 95, and 100%), cleared in xylenes, and embedded in paraffin before being cut into 5 mm thick longitudinal sections. The slices were then mounted on glass slides, deparaffinized in xylenes, and rehydrated in graded ethanol (100, 95, 70%). H&E and Masson's trichrome staining (Electron Microscopy Sciences, Hatfield, PA) were used to visualize the gross tissue morphology and confirm the presence of a bone healing response within the polymer scaffold environment.
Statistical Analysis
Data are reported as means AE the standard deviation unless otherwise noted. To determine if there was a statistically significant difference between groups (p < 0.05), mean callus scores determined by radiograph and micro-CT were evaluated by the Kruskal-Wallis test and morphometric indices obtained by micro-CT were analyzed by one-way analysis of variance followed by Tukey's post hoc test.
RESULTS
One rat in Group A experienced catastrophic failure of the fixation plate and was removed from the study. At week 4 after insertion of the PMMA spacer, Group A showed development of a robust membrane that completely surrounded the defect site upon dissection (Fig. 2) . Radiographs showed mineralized tissue ingrowth into the defect sites with callus formation visible as early as 4 weeks after scaffold insertion in all groups (Fig. 3) . Mean callus scores were 1.1 AE 0.8 for Group A, 0.7 AE 0.6 for Group B, and 0.9 AE 0.5 for Group C out of two possible points, with no significant difference observed between groups. Complete or nearly complete healing (defined as a callus score greater than 1.5) was observed in 3/7 (43%) of Group A, 1/8 (12%) of Group B, and 1/8 (12%) of Group C. 
INDUCED MEMBRANE PRECLINICAL MODEL
Micro-CT was used to quantify the total volume (TV) and mineralized bone volume (BV) within the callus as well as the newly regenerated bone mineral density. The mean TV and BV is shown in Figure 5 . Group A demonstrated significantly greater mineralized and unmineralized callus growth compared with Groups B and C, but no significant difference was found between the groups in terms of the mineralized bone fraction (BV/TV) or bone mineral density. Callus union was also scored based on the micro-CT scans. Group A had a mean score of 2.1 AE 1.0 out of three possible points, with group B having 1.2 AE 0.5 and group C having 1.6 AE 0.9. No significant difference was found between groups. Bridging of the defect, which was demonstrated by a score of two or greater, was observed in 5/7 (71%) of Group A, 1/8 (12%) of Group B, and 4/8 (50%) of Group C.
Histological analysis revealed tissue at various stages of the bone healing process in the defect sites, with extensive regeneration of mineralized bone in each experimental group (Fig. 6 ). Callus formation was observed both within and on the surface of the implanted PCL/b-TCP scaffolds. The majority of bone ingrowth into the scaffolds occurred from the proximal and distal ends. Newly formed bone and marrow tissues were found throughout the scaffolds both within the pores and in direct contact with the PCL/b-TCP struts (Fig. 7) . Histological examination of the synthetic membrane 12 weeks after implantation showed that the membrane maintained structural integrity around the defect site and supported cellular infiltration (Fig. 8) . No inflammatory reaction or fibrous encapsulation was observed in response to either the PCL//b-TCP scaffold or the synthetic membrane.
DISCUSSION
This study supports the use of a critical size femoral defect in rats as a suitable model for investigating modifications to the induced membrane technique without autograft harvest. Femoral defects filled with PMMA developed robust induced membranes surrounding the polymer spacer, leading to higher rates of bone union and greater bone volume regeneration across a PCL/b-TCP scaffold compared to the scaffold alone, although it should be noted that the BV/TV was the same among experimental groups. The presence of a microporous PCL-based sheath covering the curved side of the PCL/b-TCP scaffold did not improve the rate of bone union or bone volume regeneration. This suggests that for our model, a biologically inert membrane alone is insufficient to reproduce any of the benefits of the traditional induced membrane technique. However, the ability of the scaffold to support synthetic membrane attachment and implantation confirms our model can be used to investigate future synthetic membranes that have been engineered to reproduce the biological functionality of the induced membrane. Anecdotally, when observers reviewed the micro-CT scans, the degree of bony union seemed to correlate with the resorption of the scaffold suggesting that synthetic implant would eventually be completely replaced by bone. This hypothesis, however, would need to be investigated in future studies for validation.
Histological examination revealed the presence of regenerating bone and bone marrow tissues within the PCL/b-TCP scaffolds, and confirmed the ability of our synthetic membranes to maintain structural integrity in vivo, enabling them to protect the defect site. Cellular infiltration into the membranes was observed, demonstrating their cytocompatibility and potential to integrate with the surrounding tissues, which could be important for allowing vascular invasion into the regenerating bone.
To our knowledge, this is one of the first investigations to establish an osteogenic Masquelet inspired small animal model using traditional PMMA without bone graft in the second stage. Bosemark et al. used a similar animal model to show acellular healing of critical bone defects in a two-stage procedure with a synthetic graft. 33 This group, however, used an epoxy spacer in its first stage to induce the membrane instead of PMMA. Despite promising results, epoxy spacers are not currently FDA approved for clinical use and thus, translation of this protocol is limited. 
INDUCED MEMBRANE PRECLINICAL MODEL
Recently, McBride-Gagyi et al. used an induced membrane rat model with a similar segmental femoral defect to investigate the ability of alternative foreign materials (titanium and polyvinyl alcohol) to induce a membrane and heal critical sized bone defects. 34 At 4 weeks post index procedure, a second surgery was performed whereby the membrane was incised, the intercalary spacer was removed, and allogenic bone graft from euthanized rats was implanted to fill the defect. Presumably, allogenic bone graft was necessary for their protocol given the limitations of harvesting enough autologous bone graft from rats to fill the defect without causing severe morbidity. In comparison to our results, functional union was noted in six out of seven specimens. Another study used autologous bone graft harvested from the most caudal vertebral segments after amputation of the rat tail. 35 Although clever, their approach is clearly not translational to humans. Interestingly, this study also does not specify the exact number or percentage of unions in the grafted induced membrane group. Our technique avoided autograft harvest altogether by using an acellular synthetic scaffold alternative to replace traditional bone graft. In the future, we could further test the efficacy of osteoinductive synthetic scaffolds as an alternative to autograft to circumvent the limited autograft in rodents.
Other studies have characterized the induced membrane formed by PMMA in rat models. 11, [34] [35] [36] [37] [38] There are clear similarities between human and rat induced membrane with respect to timing of membrane formation, histological composition including osteoprogenitor cells, and presence of important growth factors such as transforming growth factor-beta (TGF-b), bone morphogenetic protein-2 (BMP-2), and vascular endothelial growth factor (VEGF). 27, 39, 40 We, therefore, differed in depth analysis of the induced membrane itself and focused on bone formation so as to not unnecessarily duplicate previously validated conclusions.
The bare synthetic PCL-based membrane did not reproduce the healing benefits of the traditional induced membrane. Several other natural and synthetic membranes for the treatment of bone defects have been attempted in dental, craniofacial and orthopaedic applications. [41] [42] [43] [44] [45] [46] [47] Researchers have successfully impregnated such membranes with bioactive agents to improve the bone and tissue regenerating properties for delivery. Thus far, these bioactive agents have included platelet derived growth factor (PDGF), 48 platelet rich plasma (PRP), 49 transforming growth factor beta-1 (TGFb-1), 50 BMP-2, 51,52 fibroblast growth factor-2 (FGF-2), 53 drugs, 54 and various combinations, 55 but many of these synthetic membranes have significant limitations in terms of mechanical strength and biocompatibility. 56 For example, collagen-based materials have been used due to their high compatibility and permeability but have difficulties in sustaining structural integrity needed for bone regeneration and an increased risk of postoperative rupture. 44, 57 Alternatively, non-resorbable polymers have been used as barrier materials; for example, expanded polytetrafluoroethylene (e-PTFE, Gore-Tex 1 ), 46 ,58 has been investigated. The main drawback of these types of materials is their non-degradability and reduced compatibility, which requires a subsequent surgery to remove the material. Incorporation of osteoinductive growth factors and, potentially, antibiotics into our biodegradable polymer membrane may prove efficacious to augment bone healing in traumatic injuries and will be subject of future study as we search for a singlestage solution for segmental bone defects.
This study has several limitations. Although the use of a PCL/b-TCP scaffold in lieu of autograft enabled our study to avoid complications associated with autograft harvesting, the polymer/ceramic grafts do not as closely reproduce current clinical practice. Use of a slowly biodegradable synthetic graft without inherent osteogenicity prevented our findings from determining whether an inert synthetic membrane could improve bone healing by preventing graft resorption. As such, our model serves primarily as a platform for investigating the essential biological properties of the induced membrane coupled with acellular scaffolds and evaluating engineered synthetic membranes with osteoinductive properties. Despite the aforementioned similarities between animal Masquelet models and human models, clear differences other than size remain. In the clinical setting, medical comorbidities and age significantly affect the ability of the host to heal. We chose relatively young rats for this investigation to optimize healing potential, which could be considered another limitation to this study.
In conclusion, a single-stage modified induced membrane technique using an engineered membrane holds promise to facilitate critical size bone defect healing with fewer required surgeries and accelerated healing times. Use of an acellular scaffold in our model reduces complications associated with donor site morbidity compared to traditional techniques. The development of an acellular Masquelet inspired model in rats establishes a preclinical platform for evaluation of engineered synthetic membranes designed to reproduce the privileged regenerative environment of the induced membrane for bone healing. 
